4 of 13
TSUTSUMI ET AL.
DIPEA (511 μL, 2.95 mmol) and EDCI HCl (563 mg, 2.95 mmol) at ice-
water bath. After stirring at ice-water bath for 1.0 hour and at room
temperature for 23 hours, the reaction mixture was concentrated
under reduced pressure. The residue was diluted with 400 mL ethyl
acetate/tetrahydrofuran (4/1) and the organic phase was washed with
10% aqueous citric acid (120 mL × 2), sat NaHCO3aq (120 mL × 2)
and sat NaClaq (100 mL × 1). The organic phase was dried over
MgSO4 and concentrated under reduced pressure. The residue was
purified by silica gel column chromatography (chloroform/
methanol = from 30/1 to 25/1 [v/v]). After drying in vacuo, com-
1H NMR (400 MHz, DMSO-d6): 8.24-7.86 (8H, m), 7.24-7.10
(20H, m), 6.40 (2H, d, J = 7.2 Hz), 4.42-4.36 (2H, m), 4.26-4.21
(2H, m), 3.81-3.78 (2H, m), 3.11-2.89 (6H, m), 2.84-2.78 (4H, m),
2.67-2.62 (2H, m), 1.77-1.66 (4H, m), 1.57-1.39 (4H, m).
MALDI-TOF MS: m/z obs. 879.21 and 901.22, calcd. 879.44
[M + H]+ and 901.42 [M + Na]+.
Compound 7b (1.22 g, 1.0 mmol) was dissolved in 10 mL
trifluoroacetic acid and the mixture was stirred at room temperature.
After stirring for 1.5 hours, the mixture was concentrated under
reduced pressure. To the residue was added 50 mL diethyl ether, and
the precipitate was collected by centrifugation (3000 rpm, for
10 minutes). The solid was suspended in 50 mL diethyl ether with
sonication and collected by centrifugation (3000 rpm, for 10 minutes).
After dry in vacuo, compound 8b was obtained as a white solid
(1.08 g, 0.95 mmol, yield 95%).
1H NMR (400 MHz, DMSO-d6): 8.19-7.76 (8H, m), 7.23-7.09
(20H, m), 6.48 (2H, d, J = 7.2 Hz), 4.42-4.33 (2H, m), 4.22-4.18
(2H, m), 3.61 (2H, bs), 3.01-2.94 (6H, m), 2.98-2.80 (4H, m), 2.71-2.65
(2H, m), 1.71 (4H, bs), 1.32 (8H, bs).
pound 7a was obtained as
a white solid (1.03 g, 0.87 mmol,
yield 65%).
1H NMR (400 MHz, DMSO-d6): 8.05 (2H, d, J = 8.4 Hz), 7.82 (2H,
t, J = 5.6 Hz), 7.23-7.06 (22H, m), 6.31 (2H, d, J = 7.2 Hz), 4.45-4.39
(2H, m), 4.31-4.26 (2H, m), 3.76-3.71 (2H, m), 3.07-3.00 (2H, m),
2.98-2.77 (8H, m), 2.70-2.65 (2H, m), 1.59-1.39 (8H, m), 1.38
(36H, bs).
MALDI-TOF MS: m/z obs. 1213.90, calcd. 1213.65 [M + Na]+.
To a solution of compound 6b (1.34 g, 2.99 mmol) in 5 mL dry
DMF was added compound 2 (485 mg, 1.36 mmol) and OxymaPure
(424 mg, 2.99 mmol) at room temperature. To this mixture was added
DIPEA (520 μL, 2.99 mmol) and EDCI HCl (572 mg, 2.99 mmol) at ice-
water bath. After stirring at ice-water bath for 1.0 hour and at room
temperature for 23 hours, the reaction mixture was concentrated
under reduced pressure. The residue was diluted with 400 mL ethyl
acetate/tetrahydrofuran (4/1) and the organic phase was washed with
10% aqueous citric acid (120 mL × 2), sat NaHCO3aq (120 mL × 2)
and sat NaClaq (100 mL × 1). The organic phase was dried over
MgSO4 and concentrated under reduced pressure. The residue was
purified by silica gel column chromatography (chloroform/
methanol = from 30/1 to 25/1 [v/v]). After drying in vacuo, com-
MALDI-TOF MS: m/z obs. 907.18 and 929.18, calcd. 907.47
[M + H]+ and 929.45 [M + Na]+.
2.3
|
Circular dichroism spectroscopy
(FFiX)2 peptides (TFA salt) were dissolved in 100 μL of an aqueous
40 mM NaOH solution at a concentration of 10 mM. The peptide
solution (100 μL) was mixed with 100 μL of 20 mM aqueous HCl solu-
tion for neutralization, and the neutralized peptide solution (5.0 mM)
was quickly diluted with ultrapure water and 20 mM Tris-HCl buffer
(pH 7.2) to prepare peptide solutions at 100 μM, 200 μM, 300 μM,
500 μM and 1000 μM in 10 mM Tris-HCl buffer (pH 7.2). The diluted
solutions were incubated at 25 ꢀC for 24 hours. Circular dichroism
(CD) spectra were recorded on a JASCO J-1100 spectropolarimeter
using a quartz cell with a 0.1 cm path length at 25 ꢀC.
pound 7b was obtained as
a white solid (1.14 g, 0.94 mmol,
yield 69%).
1H NMR (400 MHz, DMSO-d6): 8.05 (2H, d, J = 8.4 Hz), 7.80 (2H,
t, J = 5.6 Hz), 7.24-7.10 (20H, m), 7.05 (2H, d, J = 8.0 Hz), 6.33 (2H, d,
J = 7.2 Hz), 4.44-4.38 (2H, m), 4.31-4.26 (2H, m), 3.73-3.68 (2H,m),
3.09-3.01 (2H, m), 2.94-2.78 (8H, m), 2.71-2.66 (2H, m), 1.59-1.47
(4H, m), 1.38 (18H, s), 1.37 (18H, s), 1.29-1.11 (8H, m).
Neutralized peptide solution (5.0 mM) was prepared as men-
tioned above and quickly diluted with ultrapure water and 20 mM
Tris-HCl solution (pH 4.2, 7.2 or 10.2) to prepare 300 μM peptide
solution in 10 mM Tris-HCl (pH 4.2, 7.2 or 10.2). The diluted solutions
were incubated at 25 ꢀC for 24 hours.
MALDI-TOF MS: m/z obs. 1241.72, calcd. 1241.68 [M + Na]+.
2.2.8
|
Compound 8
2.4
|
Transmission electron microscopy
Compound 7a (1.19 g, 1.0 mmol) was dissolved in 10 mL
trifluoroacetic acid and the mixture was stirred at room temperature.
After stirring for 1.5 hours, the mixture was concentrated under
reduced pressure. To the residue was added 50 mL diethyl ether, and
the precipitate was collected by centrifugation (3000 rpm, for
10 minutes). The solid was suspended in 50 mL diethyl ether with
sonication and collected by centrifugation (3000 rpm, for 10 minutes).
After dry in vacuo, compound 8a was obtained as a white solid
(1.02 g, 0.92 mmol, yield 92%).
A (FFiO)2 solution at a concentration of 300 μM was prepared in
10 mM Tris-HCl buffer (pH 7.2). (FFiK)2 solutions at a concentration of
300 μM were prepared in 10 mM Tris-HCl solutions (pH 4.2, 7.2 and
10.2). These solutions were incubated at 25 ꢀC for 24 hours. A
collodion-coated copper EM grid was glow discharged for 40 seconds
at 3 mA using an IB2 ion coater. A 10 μL drop of the peptide solution
was applied to the freshly glow discharged grid for 1 minute to adsorb
peptide nanofibers. The excess solution was removed by capillary action